Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
Jack Pattillo, Former Rooster Teeth Content Creator, Twitch Streamer, and YouTuber, Named Community Manager of Channel37
From Channel37
Via GlobeNewswire
Salsify Appoints David Forlizzi as New Chief Financial Officer
From Salsify
Via GlobeNewswire
EY Announces Eric Reimer of Healthmap Solutions as an Entrepreneur Of The Year® 2024 National Award Winner
From Healthmap Solutions
Via GlobeNewswire
Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
Tickers HOWL
Locad raises $9m for smart digital logistics engine to expand globally
From Locad
Via GlobeNewswire
Route 92 Medical Gains EU and MDSAP Certification for its Neurovascular Stroke-Intervention-Focused Product Portfolio
From Route 92 Medical, Inc.
Via GlobeNewswire
Rezolve Ai and Google Sign Strategic Partnership to Revolutionize Retail and Consumer Commerce with Exclusive AI-Powered Solutions
From Rezolve AI Ltd
Via GlobeNewswire
Tickers RZLV
D. Boral Capital acted as Sole Bookrunner for Nature's Miracle Holding Inc. (NASDAQ: NMHI) in Connection with its $3.0 Million Public Offering
From D. Boral Capital
Via GlobeNewswire
Tickers NMHI
Nature’s Fynd and Justine Lupe from “Nobody Wants This” Invite Fans to Brunch In Los Angeles
From Nature's Fynd
Via GlobeNewswire
Lunawood strengthens its position in the United States – a joint venture begins thermal modification of local wood species
From Oy Lunawood Ltd
Via GlobeNewswire
ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial
From ZyVersa Therapeutics
Via GlobeNewswire
Tickers ZVSA
ACOs Using Arcadia and CareJourney Achieve 1.5x More Savings Than National Average
From Arcadia
Via GlobeNewswire
Clearlight® Unveils Exclusive VRT Spotify Playlists Created to Amplify Every Infrared Sauna Session
From Clearlight® — Infrared Saunas and Wellness Solutions
Via GlobeNewswire
HydroGraph Receives Purchase Order for Four Novel Graphenes from Global Automotive Customer
From Hydrograph Clean Power Inc.
Via GlobeNewswire
Tickers CSE:HG HGRAF
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
From 23andMe, Inc.
Via GlobeNewswire
Tickers ME
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease
From Ocugen
Via GlobeNewswire
Tickers OCGN
Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
From Aptose Biosciences, Inc.
Via GlobeNewswire
Tickers APTO TSX:APS
TRYX Launches LUCA L70 in the EU: A Stylish Debut Redefining the DIY Experience
From TRYX
Via GlobeNewswire
Announcement of Extraordinary General Meeting Results
From JSC Kaspi.kz
Via GlobeNewswire
Tickers KSPI
PyroGenesis Anticipates Positive Economic Impact from Incoming Administration in the U.S.
From PyroGenesis Inc.
Via GlobeNewswire
Tickers PYRGF TSX:PYR
NIP Group to Report Financial Results for the First Half of 2024 on November 25, 2024
From NIP GROUP INC.
Via GlobeNewswire
Tickers NIPG
Solaris Announces Final Steps to Complete Emigration by Year-End, Including Management and Board Changes; Growth-Oriented Spin-out Anticipated in 2025
From Solaris Resources
Via GlobeNewswire
Tickers TSX:SLS
Dataprana Confirms Intent to Co-Develop Its First AI Data Center in Texas
From Dataprana
Via GlobeNewswire
Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
From Recursion Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers EXAI RXRX
Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Establishing a Key IP Pillar
From Avextra AG
Via GlobeNewswire
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or ASCVD Risk Factors and/or HeFH
From NewAmsterdam Pharma N.V.
Via GlobeNewswire
Tickers NAMS NAMSW
Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights
From Septerna, Inc.
Via GlobeNewswire
Tickers SEPN
OTC Markets Group Announces Launch of MOON ATS, A New Overnight Trading Platform for National Market System (NMS) Securities
From OTC Markets
Via GlobeNewswire
Tickers OTCM
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
From C4 Therapeutics, Inc.
Via GlobeNewswire
Tickers CCCC
Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies
From CYTOMED THERAPEUTICS LIMITED
Via GlobeNewswire
Tickers GDTC
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.